KEM Hospital Research Centre, Pune
K.E.M Hospital, Pune celebrated its diamond jubilee in 1972. At that time a need was felt to further improve and expand their services.Read Further
MLN0002- "Protocol C13008: A Phase 3, open-lable study to determine the long term safety and efficacy of SMLN0002 in patients with Ulcerative Colitis and Crohn's Disease.
Research Studies/Trials Undertaken
Objective : To determine the safety profile of long-term MLN0002 treatment
MLN0002 is a humanized monoclonal antibody that binds to the α4β7 integrin, which is expressed on discrete populations of leukocytes involved in gut mucosal immunity.
Protocol No. D4280C00001: A Phase III, randomized, multicenter, double-blind, double-dummy, parallel-group, comparative study to determine the efficacy, safety, and tolerability of Ceftazidime Avibactam (CAZ-AVI) Plus Metronidazole versus Meropenem in the treatment of Complicated Intra-Abdominal Infections (cIAIs) in hospitalized adults
Objective : To assess the noninferiority of CAZ-AVI plus Metronidazole compared to Meropenem with respect to clinical cure at the test of cure visit in patients who have at least one identified pathogen.